CARLSBAD, Calif., June 15, 2016 (GLOBE NEWSWIRE) — SeaSpine Holdings Corporation (NASDAQ:SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced the full commercial launch of its Hollywood™ VI NanoMetalene® transforaminal lumbar interbody fusion device. Hollywood VI NanoMetalene, which is commercially available and has been successfully implanted, is […]

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone